Tag: Leaflex Performer
Pi-Cardia closes a US$27 million financing round led by Sofinnova Partners
Pi-Cardia has closed a US$27 million round of financing, led by Sofinnova Partners. A press rele...
Leaflex Performer: A non-implant based treatment for aortic stenosis
Given sufficient time, all bioprosthetic valves fail—whether they are surgical or transcatheter ...
EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated
Pi-Cardia has recently started its first-in-human study with its Leaflex Performer catheter system. ...
